Success Stories: Thanks to Our Assistant, a Chinese Postdoctoral Researcher in the Field of Biomedical Engineering Secures I-140 NIW Approval Without RFE

Posted by wegreened on April 12, 2025 in NIW, Technology (Nanotechnology, Nanoscience, Biomaterials, Biomechanics, Biomedical Engineering, Bioinformatics, Bioengineering, Biomedical Science, Biotechnologies)

Client’s Testimonial:

“It is a great experience working with Wegreened. They are highly responsive and provide clear, detailed instructions for each step of the process. Their flexibility in allowing me to work at my own pace was invaluable, especially when balancing other commitments during the preparation. I truly appreciate all their support and guidance!”

On March 5^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Biomedical Engineering (Approval Notice).

General Field: Biomedical Engineering

Position at the Time of Case Filing: Postdoctoral Researcher

Country of Origin: China

State of Residence at the Time of Filing: New Jersey

Approval Notice Date: March 5^th, 2025

Processing Time: 9 months, 24 days

Case Summary:

A postdoctoral researcher with a Ph.D. in biomedical engineering approached us for assistance in filing his I-140 NIW (National Interest Waiver) petition. Leveraging our extensive experience, with a proven track record of over 32,000 successful cases, our expert team meticulously crafted a compelling petition on his behalf.

To strengthen his case, we compiled a comprehensive petition packet detailing his professional and academic achievements:

His proposed endeavor is to continue his research on studying lung diseases to uncover the underlying mechanisms of abnormal lung development as well as important lung diseases, such as chronic obstructive pulmonary disease and asthma.
Our client’s research advancing his proposed endeavor is of great importance because it addresses a prominent illness that severely impacts global health. This also has broad implications for the United States. Not only is the US the biggest global spender on healthcare, but respiratory illnesses are the most significant contributors to the nation’s annual expenses.
His research has resulted in >20 peer-reviewed journal articles, >10 abstracts, and multiple grant applications and granted patents. His works have been cited a total of ~900 times, reflecting their high recognition and impact within the scientific community.
Due to his knowledge and expertise, he has been regularly invited to conduct peer reviews for authoritative conferences in the field and has conducted at least 18 reviews to date.
Furthermore, his research has been supported with funding from the National Institutes of Health, the National Natural Science Foundation of China, and the National High Technology Research and Development Program of China.

Based on his outstanding accomplishments and the established NIW criteria, our client qualifies as a professional with an advanced degree. We are delighted to share that his NIW petition was approved in 9 months and 24 days without any Requests for Evidence (RFE). It has been an incredible journey working with him, and we wish him continued success in his future endeavors.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%